US FDA OKs monthly maintenance dosing for Eisai/Biogen's Alzheimer's drug
The U.S. Food and Drug Administration has approved monthly maintenance dosing for Japan's Eisai and partner Biogen's ...
Biogen, Eisai Get FDA Nod for Leqembi IV Maintenance Dosing
Biogen and Eisai have won Food and Drug Administration approval of an intravenous maintenance dosing of their Leqembi drug for early Alzheimer's disease. The companies late Sunday said the FDA ...
Investopedia3d
How To Buy Treasury Securities
FG Trade Latin / GettyImages Investors have several ways to buy treasuries. These investments include Treasury bills, Treasury notes, Treasury bonds, Floating Rate Notes (FRNs), and Treasury ...